Author

Dustin L Orvin

Observed name: Dustin Orvin

Institution: St. Joseph’s Candler Hospital

Observed institution: St. Joseph’s Candler Hospital

ORCID: 0000-0002-2359-0168

Observed ORCID: 0000-0002-2359-0168

OpenAlex ID: A5055615429

Transitioning from guideline approval to practical implementation of AUC-based monitoring of vancomycin

2021 · Christopher M Bland, Courtney M Crosby, et al. · American Journal of Health-System Pharmacy · 9

Large-volume intravenous fluid use before and after implementation of a fluid conservation strategy

2024 · John Carr, Dustin Orvin · American Journal of Health-System Pharmacy · 8

Enteral N-acetylcysteine to reduce serum cobalt concentrations secondary to prosthetic knee–associated metallosis: A case report

2023 · Connor A Floyd, John R Carr, et al. · American Journal of Health-System Pharmacy · 3

Comment on “Consensus Recommendations for the Integration of Critical Care Pharmacists on Intensive Care Unit Teams: Endorsed by the American Association of Critical‐Care Nurses, American College of Clinical Pharmacy, American Society of Health‐System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine”

2025 · John Carr, Dustin Orvin · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY

Determining QTc in acute care settings: What we (don’t) know

2024 · Zachary Holmes, Dustin Orvin, et al. · American Journal of Health-System Pharmacy

Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Vancomycin Calculated by Area-Under-the-Curve in Patients With Elevated Vancomycin Minimum Inhibitory Concentrations

2023 · Sarah Arnold, Dustin Orvin, et al. · Hospital Pharmacy

Works count: 6

Citation count: 20

H-index: 3

I10-index: